Prestige Consumer Healthcare IncNYSE:PBH
- LAST PRICE71.2500
- TODAY'S CHANGE (%)-0.5100 (-0.7107%)
- Bid / Lots71.1200/ 4
- Ask / Lots71.2300/ 4
- Open / Previous Close71.8500 / 71.7600
- Day Range
- 52 Week Range
- Volume47,078
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PBH |
|---|---|---|
| 09:32 ET | 1020 | 71.85 |
| 09:34 ET | 120 | 71.85 |
| 09:36 ET | 500 | 71.85 |
| 09:38 ET | 9800 | 72 |
| 09:39 ET | 8301 | 71.91 |
| 09:41 ET | 1000 | 71.79 |
| 09:48 ET | 400 | 71.59 |
| 10:01 ET | 600 | 71.23 |
| 10:03 ET | 100 | 71.33 |
| 10:06 ET | 800 | 71.23 |
| 10:15 ET | 100 | 71.155 |
| 10:21 ET | 400 | 71.07 |
| 10:28 ET | 400 | 71.15 |
| 10:33 ET | 144 | 71.116 |
| 10:39 ET | 2400 | 71.235 |
| 10:44 ET | 100 | 71.25 |
| 10:46 ET | 100 | 71.265 |
| 10:48 ET | 600 | 71.23 |
| 10:51 ET | 100 | 71.2575 |
| 10:53 ET | 194 | 71.265 |
| 10:57 ET | 100 | 71.265 |
| 11:00 ET | 400 | 71.26 |
| 11:02 ET | 100 | 71.2 |
| 11:06 ET | 334 | 71.265 |
| 11:08 ET | 300 | 71.25 |
| 11:09 ET | 814 | 71.16 |
| 11:11 ET | 140 | 71.1516 |
| 11:13 ET | 200 | 71.05 |
| 11:26 ET | 600 | 71.175 |
| 11:38 ET | 100 | 71.19 |
| 11:45 ET | 110 | 71.25 |
| 11:47 ET | 152 | 71.3023 |
| 11:51 ET | 100 | 71.25 |
| 11:54 ET | 1400 | 71.25 |
Apr 25, 2024
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results, from 8:30AM ET on Thursday Apr 25, 2024 by Dow Jones
8:30AM ET on Thursday Apr 25, 2024 by Dow Jones
Apr 3, 2024
Dramamine(R) Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag, from 11:57AM ET on Wednesday Apr 03, 2024 by Dow Jones
11:57AM ET on Wednesday Apr 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Prestige Consumer Healthcare Inc | 3.6B | -43.4x | --- |
HUTCHMED (China) Ltd | 3.4B | 32.1x | --- |
Emergent BioSolutions Inc | 98.5M | -0.1x | --- |
Amphastar Pharmaceuticals Inc | 2.0B | 16.0x | --- |
Tilray Brands Inc | 1.9B | -4.0x | --- |
Corcept Therapeutics Inc | 2.4B | 25.1x | +9.80% |
Company Information
Prestige Consumer Healthcare Inc. is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. The Company operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands include Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart treatments, Little Remedies pediatric over-the-counter products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment, Debrox earwax remover, and others.
Contact Information
- Headquarters
- 660 White Plains RdTARRYTOWN, NY, United States 10591-5139
- Phone
- 914-524-6800
- Fax
- 302-674-5266
Executives
- Chairman of the Board, President, Chief Executive Officer
- Ronald Lombardi
- Chief Financial Officer
- Christine Sacco
- Executive Vice President - Marketing & Sales
- Adel Mekhail
- Senior Vice President, General Counsel, Corporate Secretary
- William P'Pool
- Senior Vice President - Operations
- Jeffrey Zerillo
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.6B |
|---|---|
Revenue (TTM) | $1.1B |
Shares Outstanding | 49.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.53 |
EPS | $-1.64 |
Book Value | $29.12 |
P/E Ratio | -43.4x |
Price/Sales (TTM) | 3.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1.83% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
